Abstract
Glutathione-responsive, paclitaxel-loaded nanoparticles based on homodithiacalix[4]arene were successfully developed, exhibiting selective drug release in cancer cells.
Original language | English |
---|---|
Pages (from-to) | 8128-8131 |
Number of pages | 4 |
Journal | Chemical communications (Cambridge, England) |
Volume | 54 |
Issue number | 58 |
DOIs | |
Publication status | Published - 2018 |